PHANews is a weekly e-newsletter providing the latest news on PH and PHA for members of the PH community.

Subscribe to PHANews

Latest Issue

Oct. 7, 2015 - FDA Approves New Treatment Combination

  • Spotlight on: FDA Approves New Treatment Combination of Ambrisentan with Tadalafil for Pulmonary Arterial Hypertension (WHO Group 1)
  • Join Us for PHA’s Congressional Luncheon – Thursday, Nov. 19
  • North Carolina Woman to Begin 30-Day Walk for a Cure
  • Periwinkle Pioneers Art Contest
  • Rock ’n’ Roll Half Marathon will Be First Meet-up and Milestone for Two Veterans Fighting PH
  • And more!

PHANews Archives

The following archives are provided for historical purposes only. Given the changing nature of the web, some links may have expired, but each past issue will still give you a sense of what was going on in the PH community at any given time.

20152014 | 2013 | 20122011 | 2010 | 2009 

PHA is proud to be able to make educational materials and programs like these available for free to everyone because of the generous support from members of the community just like you. Donations are welcome!

FacebookTwitterInstagram iconLinkedInYouTube

For optimal viewing of, please use a standards-compliant browser such as Google Chrome or Firefox.

The information provided on the PHA website is provided for general information only. It is not intended as legal, medical or other professional advice, and should not be relied upon as a substitute for consultations with qualified professionals who are familiar with your individual needs.

801 Roeder Road, Ste. 1000, Silver Spring, MD 20910   Patient-to-Patient Support Line: 1-800-748-7274
    Privacy Policy    Provide Feedback & Report Bugs

Designed by Matrix Group International, Inc.® | © 2015 Pulmonary Hypertension Association. All Rights Reserved.


The National Organization for Rare Disorders (NORD) awarded PHA the Abbey S. Meyers Leadership Award in 2012 for outstanding service to PHA members in advocacy, education and other key areas.